Lefranc-Millot C, Vercaigne-Marko D, Wal J M, Leprêtre A, Peltre G, Dhulster P, Guillochon D
Laboratoire de Technologie des Substances Naturelles, IUT A, Lille, France.
Int Arch Allergy Immunol. 1996 Jun;110(2):156-62. doi: 10.1159/000237280.
Colostral G immunoglobulins (IgGs) are described in many recent studies as having a beneficial effect for the treatment of viral, bacterial and parasitic diarrhea in animals and humans. The specific IgE titers to bovine colostral IgG, to bovine serum IgG, and to F(ab')2 fragments of IgG were immunoenzymatically quantified in sera of patients allergic to milk, to statistically evaluate and compare their relative immunoreactivity towards these purified antigens. The results clearly indicated that 36% of the population tested was potentially allergic to colostral IgG, and serum IgG globally elicited significantly lower IgE titers. The F(ab')2 fragments lead to a significantly decreased immunoreactivity as compared to colostral IgG. This study shows the interesting use of peptic hydrolysis of IgG in producing fragments with preserved therapeutic immunoactivity and reduced potential allergenicity.
近期许多研究表明,初乳中的G类免疫球蛋白(IgG)对治疗动物和人类的病毒性、细菌性及寄生虫性腹泻具有有益作用。采用免疫酶法对牛奶过敏患者血清中针对牛初乳IgG、牛血清IgG以及IgG的F(ab')2片段的特异性IgE滴度进行定量,以统计评估并比较它们对这些纯化抗原的相对免疫反应性。结果清楚地表明,36%的受试人群可能对初乳IgG过敏,并且血清IgG总体上引发的IgE滴度显著更低。与初乳IgG相比,F(ab')2片段导致免疫反应性显著降低。这项研究显示了对IgG进行胃蛋白酶水解在生产具有保留治疗免疫活性和降低潜在致敏性的片段方面的有趣应用。